company background image
BIO

Bio-Rad Laboratories NYSE:BIO Stock Report

Last Price

US$548.74

Market Cap

US$16.1b

7D

1.7%

1Y

-29.5%

Updated

13 Aug, 2022

Data

Company Financials +
BIO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BIO Stock Overview

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Bio-Rad Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bio-Rad Laboratories
Historical stock prices
Current Share PriceUS$548.74
52 Week HighUS$832.70
52 Week LowUS$462.61
Beta0.95
1 Month Change12.46%
3 Month Change9.29%
1 Year Change-29.49%
3 Year Change67.55%
5 Year Change158.32%
Change since IPO10,030.58%

Recent News & Updates

Jul 28

Bio-Rad Labs Non-GAAP EPS of $3.38 beats by $0.67, revenue of $691.1M beats by $26.5M

Bio-Rad Labs press release (NYSE:BIO): Q2 Non-GAAP EPS of $3.38 beats by $0.67. Revenue of $691.1M (-3.5% Y/Y) beats by $26.5M. For the full-year 2022, the company now anticipates non-GAAP currency-neutral revenue growth to be at the high end of the prior 1.0 to 2.0 percent guidance, with Covid-related revenue expected to be about $93 million versus approximately $70 million previously.

Shareholder Returns

BIOUS Life SciencesUS Market
7D1.7%1.9%3.2%
1Y-29.5%-19.8%-10.1%

Return vs Industry: BIO underperformed the US Life Sciences industry which returned -19.8% over the past year.

Return vs Market: BIO underperformed the US Market which returned -10.1% over the past year.

Price Volatility

Is BIO's price volatile compared to industry and market?
BIO volatility
BIO Average Weekly Movement5.6%
Life Sciences Industry Average Movement11.0%
Market Average Movement7.7%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: BIO is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: BIO's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19527,900Norman Schwartzhttps://www.bio-rad.com

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Bio-Rad Laboratories, Inc. Fundamentals Summary

How do Bio-Rad Laboratories's earnings and revenue compare to its market cap?
BIO fundamental statistics
Market CapUS$16.15b
Earnings (TTM)-US$1.94b
Revenue (TTM)US$2.87b

5.7x

P/S Ratio

-8.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIO income statement (TTM)
RevenueUS$2.87b
Cost of RevenueUS$1.21b
Gross ProfitUS$1.66b
Other ExpensesUS$3.61b
Earnings-US$1.94b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-65.41
Gross Margin57.92%
Net Profit Margin-67.66%
Debt/Equity Ratio13.3%

How did BIO perform over the long term?

See historical performance and comparison